These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18799709)

  • 1. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.
    Bility MT; Devlin-Durante MK; Blazanin N; Glick AB; Ward JM; Kang BH; Kennett MJ; Gonzalez FJ; Peters JM
    Carcinogenesis; 2008 Dec; 29(12):2406-14. PubMed ID: 18799709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
    Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.
    Zhu B; Bai R; Kennett MJ; Kang BH; Gonzalez FJ; Peters JM
    Mol Cancer Ther; 2010 Dec; 9(12):3267-77. PubMed ID: 21159610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
    Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
    Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
    Kim DJ; Prabhu KS; Gonzalez FJ; Peters JM
    Carcinogenesis; 2006 May; 27(5):1105-12. PubMed ID: 16418176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
    Burdick AD; Bility MT; Girroir EE; Billin AN; Willson TM; Gonzalez FJ; Peters JM
    Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARbeta/delta selectively induces differentiation and inhibits cell proliferation.
    Kim DJ; Bility MT; Billin AN; Willson TM; Gonzalez FJ; Peters JM
    Cell Death Differ; 2006 Jan; 13(1):53-60. PubMed ID: 16021179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.
    Borland MG; Krishnan P; Lee C; Albrecht PP; Shan W; Bility MT; Marcus CB; Lin JM; Amin S; Gonzalez FJ; Perdew GH; Peters JM
    Carcinogenesis; 2014 Jul; 35(7):1602-12. PubMed ID: 24639079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) in Keratinocytes by Endogenous Fatty Acids.
    Zhu B; Zhu X; Borland MG; Ralph DH; Chiaro CR; Krausz KW; Ntambi JM; Glick AB; Patterson AD; Perdew GH; Gonzalez FJ; Peters JM
    Biomolecules; 2024 May; 14(6):. PubMed ID: 38927010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
    Hollingshead HE; Killins RL; Borland MG; Girroir EE; Billin AN; Willson TM; Sharma AK; Amin S; Gonzalez FJ; Peters JM
    Carcinogenesis; 2007 Dec; 28(12):2641-9. PubMed ID: 17693664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.
    Girroir EE; Hollingshead HE; Billin AN; Willson TM; Robertson GP; Sharma AK; Amin S; Gonzalez FJ; Peters JM
    Toxicology; 2008 Jan; 243(1-2):236-43. PubMed ID: 18054822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
    Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
    Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM
    Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.
    Peters JM; Kim DJ; Bility MT; Borland MG; Zhu B; Gonzalez FJ
    Mol Carcinog; 2019 Sep; 58(9):1612-1622. PubMed ID: 31062422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
    Hollingshead HE; Borland MG; Billin AN; Willson TM; Gonzalez FJ; Peters JM
    Carcinogenesis; 2008 Jan; 29(1):169-76. PubMed ID: 17893232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis.
    Marin HE; Peraza MA; Billin AN; Willson TM; Ward JM; Kennett MJ; Gonzalez FJ; Peters JM
    Cancer Res; 2006 Apr; 66(8):4394-401. PubMed ID: 16618765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress.
    Zhu B; Ferry CH; Markell LK; Blazanin N; Glick AB; Gonzalez FJ; Peters JM
    J Biol Chem; 2014 Jul; 289(29):20102-19. PubMed ID: 24898257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.
    Foreman JE; Sharma AK; Amin S; Gonzalez FJ; Peters JM
    Cancer Lett; 2010 Feb; 288(2):219-25. PubMed ID: 19660859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumorigenesis by peroxisome proliferator-activated receptor (PPAR)-dependent cell cycle blocks in human skin carcinoma cells.
    Borland MG; Kehres EM; Lee C; Wagner AL; Shannon BE; Albrecht PP; Zhu B; Gonzalez FJ; Peters JM
    Toxicology; 2018 Jul; 404-405():25-32. PubMed ID: 29729928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.
    Yao PL; Chen L; Dobrzański TP; Zhu B; Kang BH; Müller R; Gonzalez FJ; Peters JM
    Mol Carcinog; 2017 May; 56(5):1472-1483. PubMed ID: 27996177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.